FIELD: chemistry, pharmaceutics.
SUBSTANCE: invention relates to novel derivatives of diaminopyrrolo quinazoline of formula (I), which possess properties of protein tyrosine phosphatase PTP-1B inhibitors and can be used for reduction of glucose concentration in blood. In general formula (I) A stands for 5- or 6-member unsaturated or saturated hydrocarbon ring or 5- or 6-member unsaturated or saturated ring, which contains at least one heteroatom, selected from S, N or O, R1 represents hydrogen or lower alkyl; Ra represents hydrogen,
,
,
,
or lower alkyl , R1, Ra, Rb, Rc, Rd, Re, Rf are such as defined in invention formula.
EFFECT: obtaining derivatives of diaminopyrrolo quinazoline which possess properties of protein tyrosine phosphatase inhibitors.
32 cl, 5 dwg, 118 ex
Title | Year | Author | Number |
---|---|---|---|
DIAMINOPYRROLOQUINAZOLINES DERIVATIVES AS PROTEINTYROSINE PHOSPHATASE INHIBITORS | 2004 |
|
RU2367664C2 |
AMINOQUINAZOLINE COMPOUNDS | 2005 |
|
RU2382034C2 |
PYRROLOPYRIMIDINE COMPOUNDS FOR MALIGNANT TUMOUR TREATMENT | 2012 |
|
RU2631655C2 |
MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC | 2005 |
|
RU2424248C2 |
NOVEL COMPOUND HAVING PARP INHIBITORY ACTIVITY | 2012 |
|
RU2606635C2 |
NOVEL AZAINDOLE THIAZOLINONES AS ANTI-CANCER AGENTS | 2005 |
|
RU2391342C2 |
ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS | 2014 |
|
RU2630693C2 |
NOVEL REVERSE AGONISTS OF CB1 RECEPTOR | 2003 |
|
RU2339618C2 |
HETEROCYCLIC ARYL SULPHONES, SUITABLE FOR TREATING DISORDERS RESPONSIVE TO 5HT RECEPTOR MODULATION | 2007 |
|
RU2451012C2 |
QUINAZOLINYLMETHYLENETRIAZOLINONES AS CDK-1 INHIBITORS | 2005 |
|
RU2405782C2 |
Authors
Dates
2009-01-27—Published
2004-05-07—Filed